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Background: Heart failure with preserved ejection fraction (HFpEF) accounts for half the cases of HF with similar mortality to heart failure with 
reduced ejection fraction. Although the mechanism is unknown, high prevalence of obesity and diabetes has been associated with HFpEF. The aim of 
this study was to assess the effect of mitochondria-targeted antioxidant on diabetes-induced diastolic dysfunction.
methods: C57BL/6J mice were fed either 60 kcal% fat diet (HFD) or 10 kcal% diet (control) for 8 weeks with or without daily intra-peritoneal 
Mito-TEMPO administration from week 4 to 8. Each group underwent ultra-high field tagged cardiac magnetic resonance imaging (CMR) and glucose 
tolerance testing prior to heart tissue harvest.
results: HFD mice developed obesity and diabetes evidenced by impaired glucose tolerance compared with the control (495 ± 45 mg/dL vs. 
236 ± 30 at 60 min after glucose challenge, p<0.05). CMR tagging detected significantly reduced diastolic strain rate in the HFD mice compared 
with the control (5.0 ± 0.3 vs. 7.4 ± 0.5, p<0.05), indicating significant diastolic dysfunction in the HFD mice. Nevertheless, left ventricular ejection 
fraction was comparable between the two groups (66.4 ± 1.4 vs. 66.7 ± 1.2, p>0.05). This diabetes-induced diastolic dysfunction was correlated 
with significant mitochondria reactive oxygen species by flow cytometry, and the resultant oxidative damage to myofibrillar proteins by western 
blotting. Mito-TEMPO treatment attenuated obesity (27.5 ± 0.9 g vs. 33 ± 0.6 g, p<0.05) and significantly improved glucose tolerance (306 ± 36 
mg/dL vs. 495 ± 45 mg/dL at 60 min after glucose challenge, p<0.05), compared with the HFD mice. CMR tagging showed mito-TEMPO treatment 
prevented diastolic dysfunction in the HFD mice as evidenced by comparable diastolic strain rate (6.5 ± 0.7 1/s vs. 7.4 ± 0.5 1/s. p>0.05) to the 
control.
conclusion: Mitochondria-targeted antioxidant treatment attenuates obesity, glucose tolerance and diastolic dysfunction, suggesting cardiac 
oxidative stress may mediate HFpEF.
